Senator FARRELL (South Australia—Minister for Trade and Tourism, Special Minister of State and Deputy Leader of the Government in the Senate) (14:07): Thank you, Senator Reynolds, for your question. I'm also a diabetic, and I very much appreciate the way in which the PBS assists me with my particular products that I am required to use. The PRESIDENT: Minister Farrell, please resume your seat. Senator Reynolds? Senator Reynolds: A question of relevance. This was about what the minister was going to do for yet another broken promise on the PBS— The PRESIDENT: Thank you, Senator Reynolds. Senator Reynolds: and it's not about his own personal medical situation. The PRESIDENT: Senator Reynolds, there was so much preamble to your supplementary that it wasn't actually a question; it was a statement. Senator Reynolds: President— The PRESIDENT: Is this a secondary point of order? Senator Reynolds: With respect, while, yes, it is a sad story of a broken promise— The PRESIDENT: Senator Reynolds, what is the point of order? Senator Reynolds: it was not about Senator Farrell's health. The PRESIDENT: Thank you. Minister Farrell. Senator FARRELL: The particular drug I think you mentioned—is it Fiasp? Yes. It's a fast-acting insulin drug for diabetes. Minister Butler's office was made aware on 22 February 2023 of Novo Nordisk's intention to— Senator Ruston: Are you going to stand by that? You can't mislead the Senate. Senator FARRELL: Please. You've asked a question; I'm directly answering the question, and then you're talking the whole way through the answer, and I don't get a chance to answer the question. (Time expired)